Lantern Pharma (LTRN) Assets (2019 - 2026)
Lantern Pharma's Assets was $8.6 million in Q2 2026, down 50.6% from $17.42 million a year earlier but up 19.1% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Assets at Lantern Pharma came in at $11.04 million, down 56.8% from FY2024.
- Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -11.5% (FY2020 to FY2025).
- In earlier years, Assets was $25.57 million in FY2024 (-41.4%), $43.65 million in FY2023 (-25.8%), $58.84 million in FY2022 (-20.4%) and $73.95 million in FY2021 (+263.2%).
- Quarterly Assets has moved between $7.22 million (Q1 2026) and $77.61 million (Q3 2021) over five years.
- Compared with a year earlier, Assets has declined for 18 straight quarters, with an average decline of 50.5% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 263.2%); the worst was Q1 2026 (a decline of 65.8%).
- Per Business Quant data, LTRN's Assets in the three quarters before Q2 2026 was $7.22 million (Q1 2026), $11.04 million (Q4 2025) and $13.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.53 Bn | 1,127.12 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 625.36 Bn | 543.89 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 510.83 Bn | 483.94 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.93 Bn | 320.31 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 296.67 Bn | 260.66 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.61 Bn | 235.29 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.27 Bn | 190.67 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.83 Bn | 168.03 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Lantern Pharma | 8.52 Mn | -27.64 Mn | - | 8.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.60 Mn |
| Mar 31, 2026 | 7.22 Mn |
| Dec 31, 2025 | 11.04 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Jun 30, 2025 | 17.42 Mn |
| Mar 31, 2025 | 21.10 Mn |
| Dec 31, 2024 | 25.57 Mn |
| Sep 30, 2024 | 30.29 Mn |
| Jun 30, 2024 | 35.59 Mn |
| Mar 31, 2024 | 39.73 Mn |
| Dec 31, 2023 | 43.65 Mn |
| Sep 30, 2023 | 47.77 Mn |
| Jun 30, 2023 | 51.43 Mn |
| Mar 31, 2023 | 55.51 Mn |
| Dec 31, 2022 | 58.84 Mn |
| Sep 30, 2022 | 62.16 Mn |
| Jun 30, 2022 | 66.38 Mn |
| Mar 31, 2022 | 68.40 Mn |
| Dec 31, 2021 | 73.95 Mn |
| Sep 30, 2021 | 77.61 Mn |
API Access
Lantern Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();